Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
SpyGlass Pharma, Inc.
SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System
May 30, 2026
SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 30, 2026
SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System
May 22, 2026
SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit
May 16, 2026
SpyGlass Pharma Announces First Patients Randomized in SGP-005 and SGP-006, Two Registrational Phase III Clinical Trials of Its Novel BIM-IOL System
January 20, 2026